Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 13:14:20 GMT 2023
by
admin
on
Sat Dec 16 13:14:20 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | IGG2/4 |
Sequence Origin | HUMANIZED MOUSE |
Sequence Type | COMPLETE |
Record UNII |
C3VX249T6L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175575
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
||
|
NCI_THESAURUS |
C308
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
||
|
FDA ORPHAN DRUG |
513015
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
||
|
FDA ORPHAN DRUG |
783320
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
||
|
FDA ORPHAN DRUG |
606917
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C124657
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
C3VX249T6L
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
10659
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
1803171-55-2
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
100000177402
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
m12119
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
Ravulizumab
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
DE-132
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
5322
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
2107301
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
C3VX249T6L
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
2107316
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
ALTERNATIVE | |||
|
Ravulizumab
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY | |||
|
DB11580
Created by
admin on Sat Dec 16 13:14:20 GMT 2023 , Edited by admin on Sat Dec 16 13:14:20 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
1_136 | 3_214 |
1_149 | 1_205 |
1_224 | 2_224 |
1_225 | 2_225 |
1_228 | 2_228 |
1_231 | 2_231 |
1_262 | 1_322 |
1_368 | 1_426 |
2_22 | 2_96 |
2_136 | 4_214 |
2_149 | 2_205 |
2_262 | 2_322 |
2_368 | 2_426 |
3_23 | 3_88 |
3_134 | 3_194 |
4_23 | 4_88 |
4_134 | 4_194 |
Glycosylation Link Type | Site |
---|---|
N | 1_298 |
N | 2_298 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INNOVATOR->PARENT |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|